BNP Paribas Financial Markets
BIOL

BNP Paribas Financial Markets’s Biolase, Inc. BIOL Stock Holding History

BNP Paribas Financial Markets’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Hold
0
– -$2.69K – 3982
2014
Q1 		– Hold
0
– – – 2575
2013
Q4 		– Sell
-1
Closed -$23.7K – 3064
2013
Q3 		$19.6K Hold
1
– – ﹤0.01% 2562
2013
Q2 		$45.4K Buy
+1
New +$55.9K ﹤0.01% 2685

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PCMI
Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

BNP Paribas Financial Markets's BIOL Position: Q2 2014 in Review

BNP Paribas Financial Markets held its Biolase, Inc. (BIOL) position steady in Q2 2014 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3982.

BNP Paribas Financial Markets first reported a position in BIOL in Q2 2013 and has held it in 2 quarters since. The position peaked at $45.4K in Q2 2013. 34 funds tracked by Wall St. Rank hold BIOL as of Q2 2014.

  • BNP Paribas Financial Markets held 0 shares of Biolase, Inc. worth $0 as of Q2 2014.
  • BNP Paribas Financial Markets left its Biolase, Inc. share count unchanged in Q2 2014.
  • Biolase, Inc. made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2014, its #3982 holding.
  • BNP Paribas Financial Markets first reported a position in Biolase, Inc. in Q2 2013 and has held it in 2 quarters since.
  • BNP Paribas Financial Markets's Biolase, Inc. position peaked at $45.4K in Q2 2013.
  • 34 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2014.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2014, filed 14 Aug 2014.